In short. Each session leaves a residue the body clears slowly. The arithmetic of treating a nose as maintenance, and what a series of top-ups does to a future operation.
Key points
- Ask what number of sessions over five years the plan implies.
- If the answer is two, it is a modest commitment.
- If the answer is eight, the plan is maintenance, and maintaining a nose in one direction is a different decision from one small adjustment.
Nothing about the injectable route is designed as a one-off. Material is placed, it fades at its own rate, and the same question returns in some months. That repetition is where the treatment changes character. One session is a small change; a habit of sessions is a slow redesign of a nose in a single direction, and it is rarely planned as such at the start.
The arithmetic of maintenance
A first session is usually small and part of the effect is lost over the following months. A top-up then restores what went, and possibly adds a little. The pattern sounds stable and it is not. Each session leaves a residue the body clears slowly, so the baseline under the skin rises even when the visible result appears unchanged. After several years the nose is not at its original size plus one treatment. It is at its original size plus everything that has not yet been cleared.
The direction is also fixed. No session removes what a previous session added. Patients treated for years often say they would like the nose they had at the start, and the routes back are waiting, dissolving where that is possible, or an operation.
Count sessions, not years
Ask what number of sessions over five years the plan implies. If the answer is two, it is a modest commitment. If the answer is eight, the plan is maintenance, and maintaining a nose in one direction is a different decision from one small adjustment.
What repeats do to a future operation
Material in the tissue changes what a surgeon works with. It is not a barrier, and operating on a nose that has been injected is routine, but the plan is different and the surgeon needs to know what is there and when it was placed. A patient who thinks an operation may eventually be wanted should say so at the first assessment rather than after five years of top-ups.
What keeps a series sensible
Three things. A written record, kept from the first session, of the substance class, the site and the amount. A review before every session, so the decision is made looking at the nose rather than at a date. And a willingness to stop when the change stops being worth the exposure. Each top-up should answer a question about what has faded and what is still wanted.
Signs the pattern has taken over
- Sessions are booked on a schedule rather than after a review of the result.
- You cannot describe the nose you are aiming for, only the last one you had.
- Nobody has written down what was placed, where and when across the whole series.
A patient who has two or three sessions over several years, each after a review, and who stops when the shape is one they are content with, has used the treatment as intended. A patient on a maintenance rhythm nobody has costed in visits has drifted into a different decision, and the nose is the thing that carries it.
Frequently asked questions
Does the effect really stay stable if I keep topping it up?
It looks stable and it is not. Each session leaves material the body clears slowly, so the baseline under the skin rises even when the visible result appears unchanged. After several years the nose holds everything that has not yet been cleared, which is more than anyone can calculate.
Is there any way to remove what previous sessions added?
Not cleanly. An injected enzyme can break down some substance classes and not others, and it does not restore the original shape even where it works. Otherwise the material clears on its own schedule, or the excess is addressed by an operation. There is no session that subtracts what an earlier session added.
Should I tell a surgeon about injections from years ago?
Yes, with dates and what you can recall of the substances. Material in the tissue changes how a surgeon plans, and the further back the series goes the more the soft tissue envelope has been affected. A record kept from the first session is far more useful than a memory five years later.
Risks & Limitations
- The nose is one of the highest-risk areas on the face for material entering a blood vessel. It is uncommon, it is time-critical, and it is not predictable from the outside.
- The route adds material and cannot remove any. A hump, a wide bridge or a deviated septum is not changed by an injection at any number of sessions.
- Reversal is unreliable. An injected enzyme can break down some substance classes and not others, and it does not restore the shape you started with.
- Each session raises the baseline under the skin. Over years the material that has not yet cleared accumulates, and there is no clean way to take it back.
- Nodules, firmness and small lumps at the injection points, which are common in the first fortnight and usually soften, but do not always.
- Bruising, swelling, tenderness and occasionally a delayed inflammatory reaction, which may need assessment and treatment rather than patience.
- The effect does not last indefinitely, its duration cannot be predicted for one person, and the change is decided as though it were final.
When to Seek Care
- Pain that is severe, is out of proportion to the injection, or is getting worse rather than easing — contact the clinic immediately.
- Skin that has blanched and not recovered, or that has turned dusky, grey or mottled.
- Any change in vision, in any part of the field, however brief — seek emergency care immediately.
- Spreading redness, warmth, swelling, discharge or fever at or near an injection site.
- A firm lump that is growing or painful, appearing weeks or months after treatment.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable and skin safety information
- American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
- U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.